ALPHA Share Price Performance
€0.0002
0.00 (0.00%)
Price €0.0002
Share Pricen/a
Pharnext S.C.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ALPHA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pharnext S.C.A. Key Details
Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
- -158.25
- -11,153.39%
- -16,004.27%
- -81.6%
About ALPHA
- Founded
- 2007
- Employees
- 19
- CEO
- WebsiteView website
Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate formulated as a pill for neurodegenerative diseases. The company was incorporated in 2007 and is headquartered in Suresnes, France.